GoodRx Holdings' Earnings May Just Be the Start of Something Big.

GoodRx Holdings' (NASDAQ:GDRX) Q4 earnings exceeded expectations, but investors were underwhelmed. The strong profit is built on solid foundations, with unusual items reducing statutory profit by $25m in the last year. Assuming these expenses don't recur, analysts expect higher profits next year. Despite the unusual items, GoodRx Holdings made a profit this year, despite losing money last year. However, investors should consider investment risks, including 2 warning signs identified by analysts.